ストックスクリーナーアプリを入手
92.10
1.15%
-1.07
前日終値:
$93.17
開ける：
$93.01
24時間の取引高:
140.47K
Relative Volume:
1.40
時価総額：
$1.18B
収益：
$86.28M
当期純損益:
$23.61M
株価収益率:
50.17
EPS:
1.8359
ネットキャッシュフロー:
$23.97M
1週間 パフォーマンス:
+6.55%
1か月 パフォーマンス:
+2.17%
6か月 パフォーマンス:
+2.88%
1年 パフォーマンス:
+76.17%
1日の値動き範囲:
$91.37
$95.47
1週間の範囲:
$85.40
$95.47
52週間の値動き範囲:
$50.88
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
92.10 | 1.19B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-04-12 | 開始されました | Lake Street | Buy |
| 2017-10-31 | 再開されました | ROTH Capital | Buy |
| 2016-10-05 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2015-11-02 | 繰り返されました | ROTH Capital | Buy |
| 2015-07-30 | 繰り返されました | ROTH Capital | Buy |
| 2015-06-16 | 繰り返されました | ROTH Capital | Buy |
| 2015-01-12 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-23 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Iradimed Corp (IRMD) 最新ニュース
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
IRMD Stock Chart | IRADIMED CORP (NASDAQ:IRMD) - ChartMill
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed CEO Roger Susi sells $657,264 in company stock - Investing.com
CEO’s trust sells 7,500 IRADIMED (IRMD) shares under Rule 10b5-1 plan - Stock Titan
IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami - Stock Titan
Iradimed (NASDAQ: IRMD) family trusts disclose 4.45M shares, 34.8% ownership - Stock Titan
IRADIMED (IRMD) CEO Susi’s trust sells 7,500 pre-planned shares - Stock Titan
Reaffirmed Outlook And Dividend: What Does IRMD’s Confidence Signal About Its MRI Pump Moat? - Yahoo Finance
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 GuidanceLearn Why - Sahm
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD (iRadimed Corporation) beats Q1 estimates with 14.4% revenue growth, but shares dip despite strong results.Earnings Surprise Stocks - Newser
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness - Yahoo Finance
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Iradimed CEO Roger Susi sells $642,861 in company stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan - Stock Titan
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - Sahm
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
A Look At IRADIMED (IRMD) Valuation After Q1 2026 Growth, New Pump Rollout And Dividend - Sahm
IRadimed Rides 3870 Momentum Despite Near-Term Dip - TipRanks
IRMD (iRadimed Corporation) tops Q1 2026 EPS estimates by 8 percent, shares rise 4.45 percent in today’s session.Open Stock Signal Network - Newser
iRadimed (NASDAQ:IRMD) Issues Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
IRadimed Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
iRadimed Corp (IRMD) Q1 2026 Earnings Call Highlights: Strong Re - GuruFocus
Why Iradimed Stock Topped the Market Today - Yahoo Finance
iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Te - GuruFocus
iRadimed Corporation (NASDAQ:IRMD) Plans Quarterly Dividend of $0.20 - MarketBeat
IRADIMED CORPORATION Files Form 8-K with SEC for May 2026 – Company Information, Address, and Stock Exchange Details - Minichart
IRADIMED CORP 1Q 2026: Revenue $21.98M, EPS $0.45— 10-Q Summary - TradingView
IRADIMED (NASDAQ: IRMD) Q1 2026 revenue rises 13% to $22M - Stock Titan
iRadimed (NASDAQ:IRMD) Sees Large Volume IncreaseShould You Buy? - MarketBeat
iRadimed Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Iradimed Co beats Q1 2026 expectations, stock dips - Investing.com
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
IRadimed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Iradimed reports Q1 2026 revenue $22.0M, GAAP EPS $0.45; declares $0.20 quarterly dividend - TradingView
iRadimed (NASDAQ:IRMD) Updates FY 2026 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Issues Q2 2026 Earnings Guidance - MarketBeat
IRADIMED ($IRMD) Releases Q1 2026 Earnings - Quiver Quantitative
IRADIMED (NASDAQ: IRMD) Q1 growth, dividend and 2026 outlook - Stock Titan
IRadimed: Q1 Earnings Snapshot - WKYC
MRI device maker IRADIMED launches new pump as Q1 sales climb 13% - Stock Titan
Roger Susi Sells 3,750 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat
Executive pay and director votes at Iradimed (NASDAQ: IRMD) 2026 meeting - Stock Titan
Iradimed CEO Susi’s trust sells $657,709 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Susi’s trust sells $657,709 in company stock - Investing.com
How The Evolving Story For IRADIMED (IRMD) Is Shaping Analyst Targets And Fair Value - Yahoo Finance
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
IRADIMED to post Q1 results before the bell May 1, call at 11 a.m. ET - Stock Titan
Iradimed Corp (IRMD) 財務データ
収益
当期純利益
現金流量
EPS
0.22%
1.41%
大文字化:
|
ボリューム (24 時間):